Global Halitosis Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
"Global Halitosis Treatment Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2027” is a recent report generated by MarketResearch.biz, which offers in-depth insights, revenue details, and other vital information regarding the global halitosis treatment market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global halitosis treatment market report has been segmented on the basis of type, indication, diagnostic test, drug treatment, and region.
Halitosis is a disease that occurs from an oral or a non-oral source. There are various causes and treatments available for halitosis which include cancer of the larynx, nasopharyngeal abscess, and lower respiratory tract infections such as asthma, bronchiectasis, chronic bronchitis, bronchiectasis, lung abscess, cystic fibrosis, interstitial lung diseases, and pneumonia. Increasing prevalence of halitosis among people is a major reason for seeking dental care, after gum disease, and tooth decay. Best method to reduce halitosis is marinatinga good oral hygiene. Various types of tests and devices available for detecting halitosis such as halimeter, gas chromatography, BANA test, and Beta-galactosidase test.
Increasing consumption of alcohol and tobacco, medical condition such as tonsils, and inflammation of nose, throat or sinuses are major factors expected to drive growth of the global halitosis treatment market over the forecast period.
In addition, rising occurrence of halitosis along with increasing awareness regarding diseases among people coupled with increasing spending on treatments are other factors expected to further fuel growth of the target market over the forecast period. For instance, according to the Bad Breath Institute study in 2018, around 35% to 45% of people across the globe suffer from bad breath at some point. Furthermore, in the US, around 80 Mn people spend more than US$ 10 Bn annually on oral hygiene products including gum, mints, mouthwashes, and toothpaste.
Furthermore, growing incidence of gastrointestinal diseases including pyloric stenosis, aorto-enteric anastomosis, duodenal obstruction, pharyngeal pouches, and zenker's diverticulum are some factors expected to boost growth of the global halitosis treatment market over the forecast period.
Moreover, diseases such as cancers, liver failure, and other metabolic diseases may cause halitosis, owing to production of specific mixtures of chemicals such as ketones in the body is another factor expected to propel growth of the global halitosis treatment market over the forecast period.
However, lack of awareness among population of emerging economies is a factor expected to restrain growth of the global halitosis treatment market over the forecast period.
Analysis by Region
The market in North America followed by Europe in the global halitosis treatment market are expected to register significant growth in terms of revenue over the forecast period, owing to growing awareness regarding bad breath and oral hygiene among people across various countries in these regions. In addition, increasing consumption of alcohol, coffee, and other sugary drinks are other factors expected to drive growth of the target market in these regions. The market in Asia Pacific is expected to register moderate growth over the forecast period, owing to increasing awareness regarding oral hygiene among individuals and increasing availability of various diagnosis and treatment of bad breath across various countries in the region.
Global halitosis treatment market segmentation:
Segmentation by type:
Segmentation by indication:
Segmentation by diagnostic test:
- Gas chromatography
- BANA test
- β-galactosidase activity assay
Segmentation by drug treatment:
Segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2017 Estimated Year 2018 Forecast Period 2018–2028 Revenue in US$
- Colgate-Palmolive Company
- Harold Katz, LLC
- Rowpar Pharmaceuticals, Inc.
- Abbott Laboratories
- Johnson & Johnson
- AstraZeneca PLC
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!